(Q40279724)

English

Validation of the use of Middlebrook 7H10 agar, BACTEC MGIT 960, and BACTEC 460 12B media for testing the susceptibility of Mycobacterium tuberculosis to levofloxacin

scientific article published on November 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Validation of the use of Middlebrook 7H10 agar, BACTEC MGIT 960, and BACTEC 460 12B media for testing the susceptibility of Mycobacterium tuberculosis to levofloxacin (English)

1 reference

Europe PubMed Central

19 September 2017

Mycobacterium tuberculosis

0 references

author name string

Cynthia A Sanders

1

1 reference

Europe PubMed Central

19 September 2017

Rachel R Nieda

2

1 reference

Europe PubMed Central

19 September 2017

Edward P Desmond

3

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

1 November 2004

1 reference

Europe PubMed Central

19 September 2017

Journal of Clinical Microbiology

1 reference

Europe PubMed Central

19 September 2017

42

1 reference

Europe PubMed Central

19 September 2017

11

1 reference

Europe PubMed Central

19 September 2017

5225-5228

1 reference

Europe PubMed Central

19 September 2017

The global tuberculosis situation. Progress and problems in the 20th century, prospects for the 21st century

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=525139

22 September 2017

Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=525139

22 September 2017

In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=525139

22 September 2017

Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=525139

22 September 2017

Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=525139

22 September 2017

In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=525139

22 September 2017

Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=525139

22 September 2017

Stability of antimycobacterial drugs in susceptibility testing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=525139

22 September 2017

Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=525139

20 August 2018

In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=525139

20 August 2018

Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15528718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycobacterial growth indicator tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15528718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS C

1 reference

https://pubmed.ncbi.nlm.nih.gov/15528718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levofloxacin for drug-resistant Mycobacterium tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15528718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/JCM.42.11.5225-5228.2004

1 reference

Europe PubMed Central

19 September 2017

release_2vjhcc54ybfnjlav5eo7aprtne

1 reference

https://api.fatcat.wiki/v0/release/2vjhcc54ybfnjlav5eo7aprtne

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40279724&oldid=1892432472"